Trevi Therapeutics
TRVI
#4836
Rank
A$2.87 B
Marketcap
A$20.17
Share price
-2.70%
Change (1 day)
18.52%
Change (1 year)

EPS for Trevi Therapeutics (TRVI)

EPS in 2026 (TTM): A-$0.50

According to Trevi Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.51. In 2025 the company made an earnings per share (EPS) of A-$0.48 an increase over its 2024 EPS that were of A-$0.71.

EPS history for Trevi Therapeutics from 2019 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.503.37%
2025A-$0.48-31.91%
2024A-$0.71
2022A-$0.85
2020A-$2.7418.17%
2019A-$2.32